November 1, 2000

1 Min Read
Lonza Group

Lonza Group

FAIR LAWN, N.J.--Lonza Group announced the Food and Drug Administration (FDA)approval of its L-carnitine L-tartrate production. During an inspection ofLonza's L-carnitine L-tartrate production last year, FDA confirmed that it foundno deviations from cGMP requirements, and have classified Lonza as an acceptablesupplier of bulk active pharmaceutical ingredients. Lonza's L-carnitine productsare free from D-carnitine, Kosher certified and fulfill all requirements underUSP and FCC. For more information, visit

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like